On-Demand Cell Line Development Webinars

  1. New Platform For Clinical Gene-Editing Of iPSCs To Make Clonal Cell Banks For The Manufacture Of Allogeneic Cell Therapies 2/28/2022

    In this webinar, we explore a platform combination for the high-efficiency, high-viability single-cell cloning of iPSCs to form the Master Cell Bank. This includes an industry-leading clonality documentation package to support future INDs.

  2. The Critical Steps For Protein Therapeutic Potency Assay Development 2/26/2022

    Learn from an expert about the process of assay development, qualification, and validation for potency assays and how we can support customers through this vital step.

  3. How A Single Provider Can Reduce Protein Biologic Development Risk 2/26/2022

    Review the problems, risks, and pain points that drug developers experience the most and explore the benefits of an integrated products and services platform for cell line development.

  4. A Data-Driven Workflow For Cell Line Development 2/25/2022

    Learn about the practicalities of integrating data-centric decision making into the cell therapy development process and how new levels of assurance, data integrity and process management can build into a more confident investigational new drug (IND) submission.

  5. Process Analytical Technology (PAT) Using Next Generation Raman For Real-Time Bioprocess Monitoring 2/8/2022

    Explore how to implement in-line and real-time monitoring of upstream cell cultures using Raman technology and how it can improve processes, save time, and reduce the risk of contamination and batch failure.

  6. Next-Gen Raman PAT For Real-Time Bioprocess Monitoring 2/3/2022

    An introduction to Raman for bioprocess monitoring, an overview of process analytical technology and real-time monitoring benefits, and practical case studies and applications for PAT.

  7. Accelerating mAb Development To Meet Increase In mAb Approvals 1/25/2022

    To accelerate the delivery of life-saving therapeutics, it is essential to evaluate ways to maximize efficiencies, while minimizing risk, to stay up to speed with the growing demand.

  8. Turnkey Solutions For Upstream Cell Culture Processes 1/19/2022

    Learn about the benefits of a one-step and neutral pH feed optimization strategy, the potential application of chemically defined hydrolysates, and supplements targeted at adjusting glycosylation attributes.

  9. Large-Scale LVV Production: Process Development To GMP Vector 12/20/2021

    Explore the key advantages of a proven approach to scale the lentiviral vector (LVV) production process (48L cf) in a bioreactor (200 L) without changing critical quality attributes (CQAs).

  10. Security Of Supply For Critical Reagents Used In HCP Analysis 12/14/2021

    For reagents, security of supply is a regulatory requirement, a factor that’s critical to consistently monitoring host cell protein (HCP) during the production of a biologic.